Biarylether amide quinolines as liver X receptor agonists

被引:43
作者
Bernotas, Ronald C. [1 ]
Singhaus, Robert R. [1 ]
Kaufman, David H. [1 ]
Ullrich, John [1 ]
Fletcher, Horace, III [1 ]
Quinet, Elaine [2 ]
Nambi, Ponnal [2 ]
Unwalla, Rayomand [1 ]
Wilhelmsson, Anna [3 ]
Goos-Nilsson, Annika [3 ]
Farnegardh, Mathias [3 ]
Wrobel, Jay [1 ]
机构
[1] Wyeth Pharmaceut, Chem & Screening Sci, Collegeville, PA 19426 USA
[2] Wyeth Pharmaceut, Cardiovasc & Metab Dis, Collegeville, PA 19426 USA
[3] Karo Bio AB, S-14157 Huddinge, Sweden
关键词
Liver X receptor; LXR; Agonist; Quinoline; ABCA1; LXR-ALPHA; CHOLESTEROL; MODULATORS; ACTIVATION; LIGAND; ACIDS;
D O I
10.1016/j.bmc.2008.12.048
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 4-(amido-biarylether)-quinolines was prepared as potential LXR agonists. Appropriate substitution with amide groups provided high affinity LXR ligands, some with excellent potency and efficacy in functional assays of LXR activity. Novel amide 4g had a binding IC50 = 1.9 nM for LXRb and EC50 = 34 nM (96% efficacy relative to T0901317) in an ABCA1 gene expression assay in mouse J774 cells, demonstrating that 4-(biarylether)-quinolines with appropriate amide substitution are potent LXR agonists (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1663 / 1670
页数:8
相关论文
共 18 条
[1]   New vistas in quinoline synthesis [J].
Atechian, Sarkis ;
Nock, Nadine ;
Norcross, Roger D. ;
Ratni, Hassen ;
Thomas, Andrew W. ;
Verron, Julien ;
Masciadri, Raffaello .
TETRAHEDRON, 2007, 63 (13) :2811-2823
[2]  
BASHA A, 1977, TETRAHEDRON LETT, P4171
[3]   An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis [J].
Bennett, D. Jonathan ;
D Brown, Lindsay ;
Cooke, Andrew J. ;
Edwards, Andrew S. .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (12) :1673-1699
[4]   Liver X receptor agonists as a treatment for atherosclerosis [J].
Bennett, DJ ;
Cooke, AJ ;
Edwards, AS ;
Moir, E ;
Ray, PC .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (07) :967-982
[5]   Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol [J].
Beyea, Michael M. ;
Heslop, Claire L. ;
Sawyez, Cynthia G. ;
Edwards, Jane Y. ;
Markle, Janet G. ;
Hegele, Robert A. ;
Huff, Murray W. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5207-5216
[6]   Ligand activation of LXRβ reverses atherosclerosis and cellular cholesterol overload in mice lacking LXRα and apoE [J].
Bradley, Michelle N. ;
Hong, Cynthia ;
Chen, Mingyi ;
Joseph, Sean B. ;
Wilpitz, Damien C. ;
Wang, Xuping ;
Lusis, Aldons J. ;
Collins, Allan ;
Hseuh, Willa A. ;
Collins, Jon L. ;
Tangirala, Rajendra K. ;
Tontonoz, Peter .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08) :2337-2346
[7]   Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines [J].
Collins, JL ;
Fivush, AM ;
Watson, MA ;
Galardi, CM ;
Lewis, MC ;
Moore, LB ;
Parks, DJ ;
Wilson, JG ;
Tippin, TK ;
Binz, JG ;
Plunket, KD ;
Morgan, DG ;
Beaudet, EJ ;
Whitney, KD ;
Kliewer, SA ;
Willson, TM .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) :1963-1966
[8]   Synthesis of diaryl ethers through the copper-promoted arylation of phenols with arylboronic acids. An expedient synthesis of thyroxine [J].
Evans, DA ;
Katz, JL ;
West, TR .
TETRAHEDRON LETTERS, 1998, 39 (19) :2937-2940
[9]  
Friedlander P., 1882, Chem. Ber, V15, P2572, DOI DOI 10.1002/CBER.188201502219
[10]   Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis [J].
Hu, Baihua ;
Collini, Michael ;
Unwalla, Rayomand ;
Miller, Christopher ;
Singhaus, Robert ;
Quinet, Elaine ;
Savio, Dawn ;
Halpern, Anita ;
Basso, Michael ;
Keith, James ;
Clerin, Valerie ;
Chen, Liang ;
Resmini, Christine ;
Liu, Qiang-Yuan ;
Feingold, Irene ;
Huselton, Christine ;
Azam, Farooq ;
Farnegardh, Mathias ;
Enroth, Cristofer ;
Bonn, Tomas ;
Goos-Nilsson, Annika ;
Wilhelmsson, Anna ;
Nambi, Ponnal ;
Wrobel, Jay .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) :6151-6154